Fig. 17
From: Multimodality imaging features of desmoid tumors: a head-to-toe spectrum
(Same patient of Fig. 16) Abdominal wall DT (T2wi in a and after contrast T1wi in b). Patient underwent to “wait and see approach” and then to CT therapy. MRI showed the variation of the signal on T2wi and of the contrast enhancement of the lesion (white arrow): after 3 months of follow-up, the lesion increased in dimension, maintained moderate contrast enhancement on T1wi (e), but became less hyperintense and more disomogeneus on T2wi. Then, the patient started a CT protocol with methotrexate and vinorelbine. After 3 years, the lesion significantly reduced its size, become strongly hypointense on T2wi (c), and did not show any significant contrast enhancement (f)